Therapeutic Exploratory (Phase II)

3,454 trials 1,368 recruiting

Filter these 3,454 trials by condition, country, sponsor and more.

Open in Search →

A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity Ended

2024-513679-42-00 Obesity 2025-04-09
Open-label basket study for safety and pharmacokinetics evaluation of INF904 in subjects with CSU or HS Ended

2024-515615-22-00 Moderate to Severe Chronic Spontaneous Urticaria (CSU) 2025-04-02
A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy and Safety of MK-1167 as Adjunctive Th… Ended

2024-515539-31-00 Alzheimer’s disease dementia 2025-04-01
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2 Ended

2024-515452-20-00 Narcolepsy Type 2 2025-04-01
SGL-TX-MR Study: The acute effect of SGLT2i on kidney transplant oxygen levels. Ended

2024-513765-40-00 Kidney transplant recipients 2025-03-27
A comparison study between adolescents with asthma and adults with asthma on how they absorb, metabolise and eliminate CHF 6001 Ended

2024-516483-29-00 Asthma 2025-03-24
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharma… Ended

2023-506723-28-00 Mitochondrial encephalomyopathy, lactic acidosis and st 2025-03-20
A study to evaluate safety and efficacy of Empasiprubart in adults with Dermatomyositis Ended

2023-508337-14-00 Myositis, Dermatomyositis 2025-03-18
Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients with… Ended

2024-514562-40-00 Hidradenitis suppurativa (HS) 2025-03-13
Axicabtagene Ciloleucel CAR T-Cells in Patients with relapsed or refractory primary mediastinal B-Cell Lymphoma Ended

2024-510972-19-00 Primary mediastinal large B-cell lymphoma (PMBCL) 2025-03-13
A Phase 2 Clinical Study in Children With HeFH Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1) Ended

2024-515864-30-00 Heterozygous familial hypercholesterolemia 2025-03-12
The sedative effects and local tolerability of nasal administration of remimazolam using a Soft Mist Nasal Administration Device Ended

2024-516493-30-01 stress anxiety 2025-03-10
A Study of the Efficacy and Safety of Brensocatib in Adults with Moderate to Severe Hidradenitis Suppurativa Ended

2024-515959-38-00 Hidradenitis Suppurativa 2025-03-06
A proof-of-concept study of lunsekimig compared with placebo in adults with chronic rhinosinusitis with nasal polyps Ended

2024-511261-11-00 Respiratory tract diseases 2025-03-05
Phase 2, randomized, double-blind, placebo-controlled study of IC0624 as first-line therapy in patients with active mild to moderate Hidrade… Ended

2024-518180-35-00 Hidradenitis Suppurativa 2025-03-03
A Study to Understand the ability and safety of GDC-8264 in Preventing kidney Injury and Major Adverse Kidney Events following Heart Surgery Ended

2024-513125-23-00 Patients with moderate to high risk for cardiac surgery 2025-02-28
An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients with Focal Onset or Primary Generalized Tonic… Ended

2024-517061-16-01 Focal onset seizures or primary generalized tonic-cloni 2025-02-27
Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults with Type 2 Diabetes M… Ended

2024-512562-34-00 Type 2 Diabetes Mellitus 2025-02-24
A weight loss study evaluating subcutaneous treatment withAZD9550 and AZD6234 in combination, against placebo or each of the drugs alone Ended

2024-516176-15-00 Investigating obesity or overweight condition correlate 2025-02-24
Pilot study on the safety and feasibility of intravenous opioid agonist therapy (OAT) with Hydagelan® (hydromorphone hydrochloride) in Vien… Ended

2024-519652-90-01 Opioid dependence: Opioid dependence is a serious and u 2025-02-17
Efficacy of intradiscal injection of autologous BM-MSC in subjects with chronic LBP due to multilevel lumbar IDD Ended

2024-519112-14-00 low back pain 2025-02-13
N/A Ended

2024-513121-22-00 Recurrent or Metastatic Head and Neck Squamous Cell Car 2025-02-04
A phase II trial to study the effectivity of combination immunotherapy in patients with prostate cancer (INSPIRE) Ended

2024-513186-39-01 castration-resistant prostate cancer 2025-02-01
Study evaluating the efficacy of the treatment after targeting PD-L1 and TIGIT in tumors with tertiary lymphoid structures Ended

2023-503218-56-00 Adult patients with a histologically confirmed TLS-posi 2025-01-30